Zhuhai Rundu Pharmaceutical Co., Ltd. (SHE:002923)
China · Delayed Price · Currency is CNY 10.17
-0.30 (-2.87%)
Jul 30, 2026, 3:04 PM CST
SHE:002923 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 3,506 | 4,069 | 3,195 | 4,133 | 4,186 | 4,552 | |
Market Cap Growth | -22.21% | 27.36% | -22.69% | -1.28% | -8.03% | 51.79% |
Enterprise Value | 3,736 | 4,410 | 3,515 | 4,502 | 4,526 | 4,553 |
Last Close Price | 10.47 | 12.15 | 9.43 | 11.97 | 11.91 | 12.59 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | 80.11 | 61.77 | 26.93 | 32.57 |
PS Ratio | 2.76 | 3.46 | 2.70 | 3.20 | 3.05 | 3.83 |
PB Ratio | 3.33 | 3.92 | 2.77 | 3.51 | 3.50 | 4.09 |
P/TBV Ratio | 3.54 | 4.17 | 2.94 | 3.71 | 3.71 | 4.36 |
P/FCF Ratio | 27.82 | 47.07 | 24.59 | - | - | - |
P/OCF Ratio | 24.59 | 38.97 | 15.13 | 23.93 | 31.01 | 22.11 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 2.94 | 3.75 | 2.97 | 3.49 | 3.30 | 3.83 |
EV/EBITDA Ratio | 28.07 | 38.48 | 20.34 | 24.70 | 19.22 | 22.95 |
EV/EBIT Ratio | - | - | 90.12 | 63.04 | 27.26 | 32.88 |
EV/FCF Ratio | 29.65 | 51.02 | 27.05 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.45 | 0.51 | 0.43 | 0.49 | 0.39 | 0.26 |
Debt / EBITDA Ratio | 3.57 | 4.57 | 2.85 | 3.11 | 1.97 | 1.42 |
Debt / FCF Ratio | 3.77 | 6.16 | 3.85 | - | - | - |
Net Debt / Equity Ratio | 0.22 | 0.27 | 0.26 | 0.30 | 0.21 | 0.03 |
Net Debt / EBITDA Ratio | 1.75 | 2.41 | 1.70 | 1.97 | 1.05 | 0.18 |
Net Debt / FCF Ratio | 1.82 | 3.19 | 2.26 | -193.53 | -2.12 | -0.21 |
Asset Turnover | 0.61 | 0.56 | 0.54 | 0.57 | 0.65 | 0.70 |
Inventory Turnover | 1.94 | 1.83 | 1.61 | 1.60 | 1.64 | 1.50 |
Quick Ratio | 0.94 | 0.85 | 0.81 | 0.96 | 0.73 | 1.06 |
Current Ratio | 1.70 | 1.60 | 1.69 | 1.94 | 1.61 | 1.91 |
Return on Equity (ROE) | -4.50% | -5.79% | 3.42% | 5.63% | 13.47% | 13.00% |
Return on Assets (ROA) | -0.36% | -0.79% | 1.10% | 1.98% | 4.95% | 5.06% |
Return on Invested Capital (ROIC) | -0.92% | -1.93% | 2.45% | 3.73% | 11.01% | 13.01% |
Return on Capital Employed (ROCE) | -0.80% | -1.80% | 2.30% | 4.00% | 9.80% | 9.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | -1.42% | -1.56% | 1.25% | 1.62% | 3.71% | 3.07% |
FCF Yield | 3.59% | 2.12% | 4.07% | -0.04% | -2.79% | -3.75% |
Dividend Yield | 1.46% | - | 1.59% | 1.67% | 2.10% | 1.75% |
Payout Ratio | - | - | 212.36% | 153.04% | 57.68% | 59.13% |
Buyback Yield / Dilution | -22.46% | -0.51% | 0.64% | 1.04% | -0.19% | -0.96% |
Total Shareholder Return | -21.00% | -0.51% | 2.23% | 2.71% | 1.91% | 0.78% |